We have shown in our previous publication that by using an antagonist to the leptin receptor we could detect a significant protection against OCR reduction induced by CM collected from obese subjects in HCT116 human colon cancer cells [12]. This evidence concerns the gene LEPR and malignant colon neoplasm.